Mini Review: Classification of Proteins Antibiotics
DOI:
https://doi.org/10.54987/jobimb.v12i2.1066Keywords:
Biosynthetic Gene Clusters (BGCs), Archaeocins and ribosomal peptides, Archaea antibiotic protein, Next-generation sequencing, BacteriocinsAbstract
The proposed classification was exclusively on the basis of biosynthetic gene clusters encoding for only antibiotic proteins. Biosynthetic gene clusters (BGCs) are organized groups of genes within the genome of prokaryotes which are involved in the production of specialized bioactive compound. These biosynthetic gene clusters contain all the genes encoding for the production of enzymes that catalysed the formation of antibiotic proteins, these include ribosomal peptides which are synthesized by the ribosome (RP), non-ribosomal peptides synthetase (NRPS).The antibiotic proteins produced by the members of the domain archaea are mainly archaeocins which are synthesized by the ribosomal pathways. Archaea have been overlooked and therefore under investigatigated for antibiotic proteins production, because only 15 achaeocins were described and characterized from haloarchaea and sulfolobus archaea, while there are many potentially untapped archaeocins in the archaeal environment, however, today there is an increase in the number of research on archaea due to the availability of molecular techniques such as 16S ribosomal RNA gene sequencing and metagenomic sequencing which revealed that they are found in not only the extreme environment but also the non-extreme (common) environment. Bacteriocins are protein toxins that inhibit the growth of similar or closely related bacterial strains at a certain concentration.Bacteriocins with their properties such as thermal tolerance and wide pH activity are now becoming promising alternatives to conventional antibiotics. Research into their production, mechanisms of action, and spectrum of activity can position them as valuable and safe antibiotic agents. Expanding research on Archaea and Bacteria using molecular techniques such as next-generation sequencing, CRISPR-Cas9 gene editing and genome mining resources (antiSMASH) can enhance the exploration and discovery of novel antibiotics and their BGCs.
References
Peterson E, Kaur P. Antibiotic resistance mechanisms in bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Front Microbiol. 2018;9:2928. doi:10.3389/fmicb.2018.02928.
Caulier S, Nannan C, Gillis A, Licciardi F, Bragard C, Mahillon J. Overview of the antimicrobial compounds produced by members of the Bacillus subtilis group. Front Microbiol. 2019;10:302. doi:10.3389/fmicb.2019.00302.
Hassan TH, Harmoosh AA. Mechanisms of antibiotic resistance in bacteria. J Syst Rev Pharm. 2020;11(6):817-23. doi:10.31838/srp.2020.6.118.
Kim A, Kwak YA. Genome-wide analysis of antibiotic-producing genes in Streptomyces globisporus SP6C4. Plant Pathol J. 2021;37(4):389-95. doi:10.5423/PPJ.NT.03.2021.0047.
Martina A, Marius S, Evi S, Nadine Z, Peter S. Mining bacterial genomes for secondary metabolite gene clusters. Methods Mol Biol. 2017;1520:9-21. doi:10.1007/978-1-4939-6634-9.
Meesil W, Paramaporn M, Sutthirat S, Triwit R, Narisara C, Ricardo AR, et al. Genome mining reveals novel biosynthetic gene clusters in entomopathogenic bacteria. Sci Rep. 2023;13:20764. doi:10.1038/s41598-023-47121-9.
Flaherty HR. Identification of novel biosynthetic gene clusters encoding for polyketide/NRPs producing chemotherapeutic compounds from marine-derived Streptomyces hygroscopicus from a marine sanctuary. Honors Theses Capstones. 2023;765. Available from: https://scholars.unh.edu/honors/765.
Yahya G, Ebada A, Khalaf EM, Mansour B, Nouh NA, Mosbah RA, et al. Soil-associated Bacillus species: a reservoir of bioactive compounds with potential therapeutic activity against human pathogens. Microorganisms. 2021;9(1131):1-18.
Andersson DI, Balaban NQ, Baquero F, Courvalin P, Glaser P, Gophna U, et al. Antibiotic resistance: turning evolutionary principles into clinical reality. FEMS Microbiol Rev. 2020;44(6):1-8.
Meade E, Mark AS, Mary G. Bacteriocins, potent antimicrobial peptides and the fight against multi-drug-resistant species: resistance is futile? Antibiotics (Basel). 2020;9(1):32. doi:10.3390/antibiotics9010032.
Field D, Cotter PD, Hill C, Ross RP. Bioengineering lantibiotics for therapeutic success. Front Microbiol. 2015;6:1363. doi:10.3389/fmicb.2015.01363.
Nes IF, Holo H. Class II antimicrobial peptides from lactic acid bacteria. Biopolymers. 2000;55:50-61.
Abriouel H, Franz CM, Omar NB, Galvez A. Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev. 2011;35(1):201-32. doi:10.1111/j.1574-6976.2010.00244.x.
Negash AW, Tsehai BA. Current applications of bacteriocins. Int J Microbiol. 2020;2020:4374891. doi:10.1155/2020/4374891.
Cetinkaya S, Osmanagaoglu O, Cokm C. Bacteriocin diversity in Bacillus sphaericus. Folia Microbiol (Praha). 2003;48:157-61.
Soltani S, Riadh H, Paul DC, Sylvie R, Laila BS, Hel G, et al. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol Rev. 2021;45:1-24. doi:10.1093/femsre/fuaa03.
McAuliffe R, Ross RP, Hill C. Lantibiotics: structure, biosynthesis, and mode of action. FEMS Microbiol Rev. 2001;25(3):285-308.
Yang S, Lin C, Sung ST, Fang J. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 2014;5:241. doi:10.3389/fmicd.2014.00241.
Asaduzzaman SM, Al-Mahin A, Bashar T, Noor R. Lantibiotics: a candidate for future generation of antibiotics. Sci J Microbiol. 2011;1(1):1-12.
Van Leeuwenhoek R. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J Bacteriol. 1928;16:321-5.
Thompson TP, Gilmore BF. Exploring halophilic environments as a source of new antibiotics. Crit Rev Microbiol. 2023;1-6. doi:10.1080/1040841X.2023.2197491.
Najjari AM, Jabbari MS, Cherif A, Ouzari HI. Halocins, bacteriocin-like antimicrobials produced by the archaeal domain: occurrence and phylogenetic diversity in Halobacteriales. Biotech Pole Sidithabet. 2020;1-11.
Niyasom C, Maminin C. Antimicrobial activity of extremely halophilic archaea isolated from southern Thai salt-fermented products and solar saltern of Pattani, Thailand. Asian J Sci Technol. 2023;26(2):20-38.
Zerin T. Isolation of Bacillus spp. from the rhizosphere of garden soil: their potential role in amylase production and nitrogen cycle. Stamford J Microbiol. 2020;10:12-5. doi:10.3329/sjm.v10i1.50726.
Manzum AA, Mamun MAA. Isolation of Bacillus bacteria from soil for production of cellulase. Nepal J Biotechnol. 2019;6(1):57-61. doi:10.3126/njb.v6i1.22338.
Dincer H, Aysun MT, Melis SO. Nonribosomal peptide synthesis. IntechOpen. 2022. doi:10.5772/intechopen.104722.
Mishra SH. Generating novel antibiotics from non-ribosomal peptide synthetases. Adv Tech Biol Med. 2014;2(106):1-5. doi:10.4172/2379-1764.1000e106.
Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2015;40(9):1333-41. doi:10.1086/429323.
Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock RW. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother. 2002;46(3):605-14. doi:10.1128/aac.46.3.605-614.2002.
Braun RK, Raines RT, Lukesh JC, Tsao F, Eldridge M, Meyer KC. Successful treatment of bleomycin-induced lung fibrosis by a modified antioxidant C75. Am Thorac Soc Int Conf. 2017;A6355. doi:10.1164/ajrccmconference.2017.195.1_meetingabstracts.a6355.
Miao V, Marie-Franc CG, Paul B, Renee B, Julia P, Andrew W, et al. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology (Reading). 2005;151:1507-23. doi:10.1099/mic.0.27757-0.
Heidary M, Azar DK, Saeed KM, Saleh S, Mehdi G. Daptomycin. J Antimicrob Chemother. 2018;73:1-11. doi:10.1093/jac/dkx349.
Cha R, Brown WJ, Rybak MJ. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother. 2003;47:3960-3.
Binda E, Marinelli F, Marcone GL. Old and new glycopeptide antibiotics: action and resistance. Antibiotics (Basel). 2014;3:572-94.
Hee-Kyoung K, Yoonkyung P. Glycopeptide antibiotics: structure and mechanisms of action. J Bacteriol Virol. 2015;45(2):67-78. doi:10.4167/jbv.2015.45.2.67.
Ebimi EE, Arikekpar I. Antibiotics: classification and mechanisms of action with emphasis on molecular perspectives. Int J Appl Microbiol Biotechnol Res. 2016;4:90-101.
Yim G, Thaker MN, Koteva K, Wright G. Glycopeptide antibiotic biosynthesis. J Antibiot (Tokyo). 2014;67:31-41.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tasiu Mahmud, Ibrahim Alhaji Sabo, Yahaya Ubah Yau
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
